| Basics |
Exact Sciences Corporation
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
|
| IPO Date: |
January 31, 2001 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$10.59B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.75 | 2.71%
|
| Avg Daily Range (30 D): |
$0.84 | 1.61%
|
| Avg Daily Range (90 D): |
$0.97 | 2.04%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.2M |
| Avg Daily Volume (30 D): |
2.35M |
| Avg Daily Volume (90 D): |
2.08M |
| Trade Size |
| Avg Trade Size (Sh.): |
103 |
| Avg Trade Size (Sh.) (30 D): |
64 |
| Avg Trade Size (Sh.) (90 D): |
65 |
| Institutional Trades |
| Total Inst.Trades: |
19,004 |
| Avg Inst. Trade: |
$3.11M |
| Avg Inst. Trade (30 D): |
$4.73M |
| Avg Inst. Trade (90 D): |
$3.77M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
6 |
| Market Closing Trades |
| Avg Closing Trade: |
$9.92M |
| Avg Closing Trade (30 D): |
$22.13M |
| Avg Closing Trade (90 D): |
$17.89M |
| Avg Closing Volume: |
172.07K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q3 2024 |
|
Basic EPS
|
|
$-.54
|
$-.21
|
|
Diluted EPS
|
|
$-.54
|
$-.21
|
|
Revenue
|
$
|
$ 706.79M
|
$ 708.66M
|
|
Gross Profit
|
$
|
$ 500.55M
|
$ 512.59M
|
|
Net Income / Loss
|
$
|
$ -101.22M
|
$ -38.24M
|
|
Operating Income / Loss
|
$
|
$ -96.01M
|
$ -39.4M
|
|
Cost of Revenue
|
$
|
$ 206.24M
|
$ 196.07M
|
|
Net Cash Flow
|
$
|
$ -259.51M
|
$ 58.65M
|
|
PE Ratio
|
|
|
|
|
|
|
